Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

#stocks #bullish #buys #analysts #research #WallStreet

$ACAD $BIGC $BMY $CHWY $HOLX $MCAF

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below are our Buy calls for Tuesday, 17 November, as follows:

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) was raised to Strong Buy from Outperform with a 65 price target at Raymond James.

BigCommerce Holdings Inc. (NASDAQ:BIGC) was raised to Buy from Hold but its 95 price target was maintained at Truist Securities. Also, Stifel started it with a Buy rating and an 80 price target.

Bristol-Myers Squibb Co. (NYSE:BMY) was raised to Buy from Hold with a 76 price target at Societe Generale. The stock has a 73.18 consensus target price.

Chewy Inc. (NYSE:CHWY) was started as Buy and its price target set at 75 at Needham.

Hologic Inc. (NASDAQ:HOLX):this leader in women’s health diagnostics is ramping high double-digit growth on COVID testing. Shares have a consensus price target of 86.36.

McAfee Corp. (NASDAQ:MCAF) Goldman Sachs started it as Buy with a 26 price target.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.